亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Robotic versus Electromagnetic bronchoscopy for pulmonary LesIon AssessmeNT: the RELIANT pragmatic randomized trial

医学 支气管镜检查 肺病学 随机化 随机对照试验 临床终点 整群随机对照试验 放射科 外科 内科学
作者
Rafael Paez,Robert J. Lentz,Cristina Salmon,Justin K. Siemann,See‐Wei Low,Jonathan D. Casey,Heidi Chen,Sheau-Chiann Chen,Sameer K. Avasarala,Samira Shojaee,Otis B. Rickman,Christopher J. Lindsell,Cheryl L. Gatto,Todd W. Rice,Fabien Maldonado
出处
期刊:Trials [Springer Nature]
卷期号:25 (1) 被引量:1
标识
DOI:10.1186/s13063-023-07863-3
摘要

Abstract Background Robotic-assisted bronchoscopy has recently emerged as an alternative to electromagnetic navigational bronchoscopy for the evaluation of peripheral pulmonary lesions. While robotic-assisted bronchoscopy is proposed to have several advantages, such as an easier learning curve, it is unclear if it has comparable diagnostic utility as electromagnetic navigational bronchoscopy. Methods R obotic versus E lectromagnetic bronchoscopy for pulmonary L es I on A ssessme NT (RELIANT) is an investigator-initiated, single-center, open label, noninferiority, cluster randomized controlled trial conducted in two operating rooms at Vanderbilt University Medical Center. Each operating room (OR) is assigned to either robotic-assisted or electromagnetic navigational bronchoscopy each morning, with each OR day considered one cluster. All patients undergoing diagnostic bronchoscopy for evaluation of a peripheral pulmonary lesion in one of the two operating rooms are eligible. Schedulers, patients, and proceduralists are blinded to daily group allocations until randomization is revealed for each operating room each morning. The primary endpoint is the diagnostic yield defined as the proportion of cases yielding lesional tissue. Secondary and safety endpoints include procedure duration and procedural complications. Enrolment began on March 6, 2023, and will continue until 202 clusters have been accrued, with expected enrolment of approximately 400 patients by the time of completion in March of 2024. Discussion RELIANT is a pragmatic randomized controlled trial that will compare the diagnostic yield of the two most commonly used bronchoscopic approaches for sampling peripheral pulmonary lesions. This will be the first known cluster randomized pragmatic trial in the interventional pulmonology field and the first randomized controlled trial of robotic-assisted bronchoscopy. Trial registration ClinicalTrials.gov registration (NCT05705544) on January 30, 2023.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
深情安青应助123456采纳,获得10
5秒前
薛沛然发布了新的文献求助30
9秒前
10秒前
王子羊发布了新的文献求助10
10秒前
14秒前
16秒前
morena发布了新的文献求助10
18秒前
19秒前
NexusExplorer应助薛沛然采纳,获得10
20秒前
Yoyoyuan发布了新的文献求助10
22秒前
休斯顿完成签到,获得积分10
23秒前
24秒前
Rn完成签到 ,获得积分0
25秒前
27秒前
真实的小伙完成签到,获得积分10
29秒前
CCDR发布了新的文献求助10
29秒前
薛沛然完成签到,获得积分10
31秒前
mm完成签到 ,获得积分10
31秒前
32秒前
mars完成签到,获得积分10
39秒前
Orange应助163采纳,获得10
39秒前
41秒前
Orange应助科研通管家采纳,获得10
43秒前
深情安青应助科研通管家采纳,获得10
43秒前
43秒前
很好的发布了新的文献求助10
47秒前
奥特曼吃不胖完成签到 ,获得积分10
47秒前
47秒前
王子羊完成签到,获得积分10
48秒前
mars发布了新的文献求助10
49秒前
Ava应助安详以松采纳,获得10
50秒前
小猫蛋堡发布了新的文献求助10
51秒前
很好的完成签到,获得积分20
57秒前
大派完成签到,获得积分10
59秒前
乐乐应助沉默的早晨采纳,获得10
1分钟前
1分钟前
newmoon完成签到 ,获得积分10
1分钟前
王喆发布了新的文献求助10
1分钟前
积极易烟完成签到,获得积分20
1分钟前
123456发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Digital Twins of Advanced Materials Processing 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6042149
求助须知:如何正确求助?哪些是违规求助? 7788649
关于积分的说明 16236687
捐赠科研通 5188067
什么是DOI,文献DOI怎么找? 2776201
邀请新用户注册赠送积分活动 1759312
关于科研通互助平台的介绍 1642757